Cargando…
Efficacy of positive airway pressure therapy and high flow nasal cannula oxygen in acute cardiogenic pulmonary oedema: A protocol for systematic review and network meta-analysis
INTRODUCTION: Positive airway pressure (PAP) therapy is currently the first-line respiratory support technique for acute respiratory failure (ARF) due to acute cardiogenic pulmonary edema (ACPE), but the accompanied adverse events and patient's intolerance with treatment in some cases limited i...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767974/ https://www.ncbi.nlm.nih.gov/pubmed/36569169 http://dx.doi.org/10.3389/fmed.2022.992491 |
_version_ | 1784854072347590656 |
---|---|
author | Niu, Jianyi He, Zhenfeng Zha, Shanshan Huang, Qiaoyun Fu, Wei Feng, Shengchuan Guan, Lili Zhou, Luqian Chen, Rongchang |
author_facet | Niu, Jianyi He, Zhenfeng Zha, Shanshan Huang, Qiaoyun Fu, Wei Feng, Shengchuan Guan, Lili Zhou, Luqian Chen, Rongchang |
author_sort | Niu, Jianyi |
collection | PubMed |
description | INTRODUCTION: Positive airway pressure (PAP) therapy is currently the first-line respiratory support technique for acute respiratory failure (ARF) due to acute cardiogenic pulmonary edema (ACPE), but the accompanied adverse events and patient's intolerance with treatment in some cases limited its use in clinical practice. Some recent trials indicated that high-flow nasal cannula oxygen (HFNO) is a promising alternative to PAP therapy. In order to choose the optimum treatment for patients with ACPE, this network meta-analysis will firstly compares the efficacy of HFNO, PAP, and conventional oxygen therapy (COT). METHODS AND ANALYSIS: The Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols 2015 statement and its extension for network meta-analysis will be followed in the conduct of this investigation. We will examine these databases: PubMed, EMBASE, Cochrane Central Register of Controlled Trials and Web of Science. The ClinicalTrials.gov and World Health Organization International Clinical Trials Registry Platform Search Portal will be used to search ongoing trials. Only randomized controlled trials meeting the eligibility criteria will be included. Through the Cochrane Collaboration's tool, the included studies' risk of bias will be assessed. The pairwise meta-analysis will be performed with RevMan 5.4.1 software. A Bayesian network meta-analysis will use random-effects models to derive odds ratios for the treatment effects of all interventions compared to each other using R software (version 3.6.1), and the rjags and gemtc packages. The Q statistic and I(2) index will be used for investigating the heterogeneity, and subgroup analysis or sensitivity analysis will be used to explore the source of heterogeneity. In addition, the Grading of Recommendations Assessment, Development and Evaluation system will be used to inspect the quality of evidence. |
format | Online Article Text |
id | pubmed-9767974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97679742022-12-22 Efficacy of positive airway pressure therapy and high flow nasal cannula oxygen in acute cardiogenic pulmonary oedema: A protocol for systematic review and network meta-analysis Niu, Jianyi He, Zhenfeng Zha, Shanshan Huang, Qiaoyun Fu, Wei Feng, Shengchuan Guan, Lili Zhou, Luqian Chen, Rongchang Front Med (Lausanne) Medicine INTRODUCTION: Positive airway pressure (PAP) therapy is currently the first-line respiratory support technique for acute respiratory failure (ARF) due to acute cardiogenic pulmonary edema (ACPE), but the accompanied adverse events and patient's intolerance with treatment in some cases limited its use in clinical practice. Some recent trials indicated that high-flow nasal cannula oxygen (HFNO) is a promising alternative to PAP therapy. In order to choose the optimum treatment for patients with ACPE, this network meta-analysis will firstly compares the efficacy of HFNO, PAP, and conventional oxygen therapy (COT). METHODS AND ANALYSIS: The Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols 2015 statement and its extension for network meta-analysis will be followed in the conduct of this investigation. We will examine these databases: PubMed, EMBASE, Cochrane Central Register of Controlled Trials and Web of Science. The ClinicalTrials.gov and World Health Organization International Clinical Trials Registry Platform Search Portal will be used to search ongoing trials. Only randomized controlled trials meeting the eligibility criteria will be included. Through the Cochrane Collaboration's tool, the included studies' risk of bias will be assessed. The pairwise meta-analysis will be performed with RevMan 5.4.1 software. A Bayesian network meta-analysis will use random-effects models to derive odds ratios for the treatment effects of all interventions compared to each other using R software (version 3.6.1), and the rjags and gemtc packages. The Q statistic and I(2) index will be used for investigating the heterogeneity, and subgroup analysis or sensitivity analysis will be used to explore the source of heterogeneity. In addition, the Grading of Recommendations Assessment, Development and Evaluation system will be used to inspect the quality of evidence. Frontiers Media S.A. 2022-12-07 /pmc/articles/PMC9767974/ /pubmed/36569169 http://dx.doi.org/10.3389/fmed.2022.992491 Text en Copyright © 2022 Niu, He, Zha, Huang, Fu, Feng, Guan, Zhou and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Niu, Jianyi He, Zhenfeng Zha, Shanshan Huang, Qiaoyun Fu, Wei Feng, Shengchuan Guan, Lili Zhou, Luqian Chen, Rongchang Efficacy of positive airway pressure therapy and high flow nasal cannula oxygen in acute cardiogenic pulmonary oedema: A protocol for systematic review and network meta-analysis |
title | Efficacy of positive airway pressure therapy and high flow nasal cannula oxygen in acute cardiogenic pulmonary oedema: A protocol for systematic review and network meta-analysis |
title_full | Efficacy of positive airway pressure therapy and high flow nasal cannula oxygen in acute cardiogenic pulmonary oedema: A protocol for systematic review and network meta-analysis |
title_fullStr | Efficacy of positive airway pressure therapy and high flow nasal cannula oxygen in acute cardiogenic pulmonary oedema: A protocol for systematic review and network meta-analysis |
title_full_unstemmed | Efficacy of positive airway pressure therapy and high flow nasal cannula oxygen in acute cardiogenic pulmonary oedema: A protocol for systematic review and network meta-analysis |
title_short | Efficacy of positive airway pressure therapy and high flow nasal cannula oxygen in acute cardiogenic pulmonary oedema: A protocol for systematic review and network meta-analysis |
title_sort | efficacy of positive airway pressure therapy and high flow nasal cannula oxygen in acute cardiogenic pulmonary oedema: a protocol for systematic review and network meta-analysis |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767974/ https://www.ncbi.nlm.nih.gov/pubmed/36569169 http://dx.doi.org/10.3389/fmed.2022.992491 |
work_keys_str_mv | AT niujianyi efficacyofpositiveairwaypressuretherapyandhighflownasalcannulaoxygeninacutecardiogenicpulmonaryoedemaaprotocolforsystematicreviewandnetworkmetaanalysis AT hezhenfeng efficacyofpositiveairwaypressuretherapyandhighflownasalcannulaoxygeninacutecardiogenicpulmonaryoedemaaprotocolforsystematicreviewandnetworkmetaanalysis AT zhashanshan efficacyofpositiveairwaypressuretherapyandhighflownasalcannulaoxygeninacutecardiogenicpulmonaryoedemaaprotocolforsystematicreviewandnetworkmetaanalysis AT huangqiaoyun efficacyofpositiveairwaypressuretherapyandhighflownasalcannulaoxygeninacutecardiogenicpulmonaryoedemaaprotocolforsystematicreviewandnetworkmetaanalysis AT fuwei efficacyofpositiveairwaypressuretherapyandhighflownasalcannulaoxygeninacutecardiogenicpulmonaryoedemaaprotocolforsystematicreviewandnetworkmetaanalysis AT fengshengchuan efficacyofpositiveairwaypressuretherapyandhighflownasalcannulaoxygeninacutecardiogenicpulmonaryoedemaaprotocolforsystematicreviewandnetworkmetaanalysis AT guanlili efficacyofpositiveairwaypressuretherapyandhighflownasalcannulaoxygeninacutecardiogenicpulmonaryoedemaaprotocolforsystematicreviewandnetworkmetaanalysis AT zhouluqian efficacyofpositiveairwaypressuretherapyandhighflownasalcannulaoxygeninacutecardiogenicpulmonaryoedemaaprotocolforsystematicreviewandnetworkmetaanalysis AT chenrongchang efficacyofpositiveairwaypressuretherapyandhighflownasalcannulaoxygeninacutecardiogenicpulmonaryoedemaaprotocolforsystematicreviewandnetworkmetaanalysis |